Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 6/20 | 0.72 |
| ▸ | HTR2C | P28335 | 1/20 | 0.72 |
| ▸ | PGR | P06401 | 3/20 | 0.72 |
| ▸ | PPARG | P37231 | 2/20 | 0.70 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.70 |
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.70 |
| ▸ | SLC22A11 | Q9NSA0 | 2/20 | 0.70 |
| ▸ | DAO | P14920 | 1/20 | 0.70 |
| ▸ | SNCA | P37840 | 1/20 | 0.70 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.70 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 5/20 | 0.69 |
| ▸ | ALB | P02768 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.62 |
| ▸ | APEX1 | P27695 | 3/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | RECQL | P46063 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cefuzonam SCHEMBL2984090 | 1.00 | NR1I2 (0.72) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL27637852 | 1.00 | NR1I2 (0.72) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL149485 | 0.99 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL10363005 | 0.99 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL11144468 | 0.99 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL9573537 | 0.99 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL149484 | 0.99 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL4811935 | 0.99 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL11144465 | 0.99 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL4811952 | 0.99 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2136844-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | Centre De Recherche Sur Les Biotechnologies Marine (CA) | 2009-12-30 | — | — | EP | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| WO-2008113177-A1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2008-09-25 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| EP-3181616-B1 | CELLULOSE MICROPOWDER | ASAHI CHEMICAL IND (JP) | 2021-09-15 | — | — | EP | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| EP-2486917-B1 | COATING FILM, AND GRANULES AND TABLETS EACH UTILIZING SAME | ASAHI CHEMICAL IND (JP) | 2020-11-25 | — | — | EP | disclosed |
| EP-2184056-B1 | PROCESS FOR PRODUCTION OF TABLETS CONTAINING BOTH CRYSTALLINE CELLULOSE AND GRANULES | ASAHI CHEMICAL IND (JP) | 2019-04-24 | — | — | EP | disclosed |
| EP-2136844-B1 | COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF | SCF PHARMA INC (CA) | 2018-10-31 | — | — | EP | disclosed |
| US-10016367-B2 | Cellulose micropowder | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-07-10 | — | — | US | disclosed |
| US-9925165-B2 | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof | SCF PHARMA INC. (CA) | 2018-03-27 | — | — | US | disclosed |
| US-20170258728-A1 | CELLULOSE MICROPOWDER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2017-09-14 | — | — | US | disclosed |
| CN-1671383-A | Sustained release tablet containing reboxetine | PHARMACIA CORP (US) | 2005-09-21 | — | — | CN | disclosed |
| CN-1517090-A | Animal use suspensoid injection or emulsion containing antibacterial medicine | 王玉万 | 2004-08-04 | — | — | CN | disclosed |
| US-6416546-B1 | Medical device and production method thereof | UNITIKA LTD. (JP) | 2002-07-09 | — | — | US | disclosed |
| EP-1190706-A1 | LIPOSOMES | TERUMO KABUSHIKI KAISHA (JP) | 2002-03-27 | — | — | EP | disclosed |
| EP-0665009-B1 | CRYSTALLINE CONDITION DISLOCATING METHOD | NIPPON SHINYAKU CO LTD (JP) | 2000-02-16 | — | — | EP | disclosed |
| EP-0882461-A2 | Medical device and production method thereof | UNITIKA LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | disclosed |
| EP-0665009-A1 | CRYSTALLINE CONDITION DISLOCATING METHOD | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1995-08-02 | — | — | EP | disclosed |